InMode (INMD) Shareholder's Equity (2018 - 2026)

InMode (INMD) Shareholder's Equity (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 52.06 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 22.98 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 49.20 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 26.10 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 10.33 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 13.34 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 2.96 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.67 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 7.20 Bn
10 InMode 3.35 -388.37 Mn 61.55 Mn 661.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 661.25 Mn
Dec 31, 2025 683.20 Mn
Sep 30, 2025 653.39 Mn
Jun 30, 2025 628.44 Mn
Mar 31, 2025 619.43 Mn
Dec 31, 2024 703.81 Mn
Sep 30, 2024 736.89 Mn
Jun 30, 2024 751.12 Mn
Mar 31, 2024 815.44 Mn
Dec 31, 2023 787.37 Mn
Sep 30, 2023 723.50 Mn
Jun 30, 2023 666.16 Mn
Mar 31, 2023 602.98 Mn
Dec 31, 2022 554.62 Mn
Sep 30, 2022 508.30 Mn
Jun 30, 2022 452.81 Mn
Mar 31, 2022 403.32 Mn
Dec 31, 2021 415.80 Mn
Sep 30, 2021 384.03 Mn
Jun 30, 2021 331.18 Mn